Side-effects of antiepileptic drugs: The economic burden
- 1 March 2014
- journal article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 23 (3) , 184-190
Abstract
No abstract availableKeywords
Funding Information
- Netherlands Organization for Health Research and Development (ZonMW) (171002204)
This publication has 32 references indexed in Scilit:
- Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessmentsEpilepsia, 2011
- Adjustment of treatment increases quality of life in patients with epilepsy: a randomized controlled pragmatic trialEuropean Journal of Neurology, 2009
- Adverse antiepileptic drug effectsNeurology, 2009
- Complaints associated with the use of antiepileptic drugs: results from a community-based studySeizure: European Journal of Epilepsy, 2005
- Estimating the Costs of Epilepsy: An International Comparison of Epilepsy Cost StudiesEpilepsia, 2001
- Comparing the cost of epilepsy across eight European countriesEpilepsy Research, 2001
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- The burden of epilepsy for the patient: the intangible costs.Epilepsia, 1999
- Payer Costs of Patients Diagnosed with EpilepsyEpilepsia, 1999
- Cost of Epilepsy in the United States: A Model Based on Incidence and PrognosisEpilepsia, 1994